Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2013
11/28/2013WO2013175388A1 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
11/28/2013WO2013174781A1 5-amino[1,4]thiazines as bace 1 inhibitors
11/28/2013US20130317231 Amidobenzothiazoles And Process For The Preparation Thereof
11/28/2013US20130317219 Benzothiazole Derivatives
11/28/2013US20130317218 Novel bicyclic thiazole compounds
11/28/2013US20130317216 2,4-pyrimidinediamine compounds and their uses
11/28/2013US20130317065 Indole derivative and pharmacologically acceptable salt thereof
11/28/2013US20130317064 Microbiocidal pyrazole derivatives
11/28/2013US20130317061 Crystalline Salts of a Potent HCV Inhibitor
11/28/2013US20130317044 Novel carboxylic acid derivatives, their preparation and use
11/28/2013US20130317032 Thiazole and thiadiazole compounds for inflammation and immune-related uses
11/28/2013US20130317029 Oxypyrimidines as syk modulators
11/28/2013US20130316999 Substituted oxazolidinones and their use in the field of blood coagulation
11/28/2013US20130316981 Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
11/27/2013EP2666768A2 Condensed-cyclic compound and organic light-emitting diode comprising the same
11/27/2013EP2665709A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
11/27/2013EP2665704A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
11/27/2013EP2665479A1 Methods and drug products for treating alzheimer's disease
11/27/2013CN103415507A 3-amino-pyridines as GPBAR1 agonists
11/27/2013CN103408542A Preparation method of high-purity anhydrous dasatinib
11/27/2013CN103408541A Indole-substituted thiazolo cyclohexane compound and antineoplastic applications thereof
11/27/2013CN103408540A 2-imidazole ring-substituted thiophene PLK1 (Polo-like kinase 1) inhibitors and applications thereof
11/27/2013CN103408533A Novel substituted pyridin-2-ones and pyridazin-3-ones
11/27/2013CN102660257B Phenothiazinyl quinazoline fluorescence ion probe and application thereof
11/27/2013CN101977900B 5-fluoro pyrimidine derivatives
11/26/2013US8592457 Isonicotinamide orexin receptor antagonists
11/26/2013CA2649736C Heterocyclic compounds as inhibitors of c-fms kinase
11/26/2013CA2335240C Cyanine dyes and synthesis methods thereof
11/21/2013WO2013173382A1 Benzothiophene sulfonamides and other compounds that interact with glucokinase regulatory protein
11/21/2013WO2013172255A1 Compound, light emitting material, and organic light emitting element
11/21/2013WO2013171642A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171281A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/21/2013US20130310562 Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors
11/21/2013US20130310432 Novel thiazolidin-4-one-derivatives
11/21/2013US20130310429 ITE for Cancer Intervention and Eradication
11/21/2013US20130310427 Inhibitors of hcv ns5a protein
11/21/2013US20130310393 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators
11/21/2013US20130310377 Novel modulators of calcium release-activated calcium channel
11/21/2013US20130310375 N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
11/21/2013US20130310365 Cyclohexyl-azetidinyl antagonists of ccr2
11/21/2013US20130310358 Pyrimidine compounds as delta opioid receptor modulators
11/21/2013US20130310348 Quinoline derivatives and uses thereof
11/21/2013US20130310342 Aminopyrimidine Kinase Inhibitors
11/21/2013US20130309272 Compounds for inflammation and immune-related uses
11/21/2013US20130309197 Inhibitors of cytochrome p450
11/21/2013CA2877026A1 Method for the preparation of thiadiazoles
11/20/2013EP2664616A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/20/2013EP2663553A2 Quinoline and isoquinoline compounds and methods of use thereof
11/20/2013EP2514750B1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
11/20/2013EP2407451B1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/20/2013EP2403832B1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
11/20/2013EP2389226B1 Bridged and fused heterocyclic antidiabetic compounds
11/20/2013EP2246338B1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
11/20/2013EP2007747B1 Process for preparing heterocyclic derivatives
11/20/2013EP1809624B1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/20/2013EP1801108B9 Morpholine compounds for the treatment of inflammations
11/20/2013EP1765805B1 Cgrp receptor antagonists
11/20/2013CN103403582A Curable coloring composition, color filter and manufacturing method for same, liquid crystal display device, solid-state image-capturing device, and dye compound.
11/20/2013CN103403002A Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
11/20/2013CN103402996A Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD)
11/20/2013CN103402987A 6-amino-2-phenylamino-1H-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin E2 synthase-1 inhibitors
11/20/2013CN103402985A Microbiocidal pyrazole derivatives
11/20/2013CN103402982A Synthesis of 2-carboxamide cycloamino urea derivatives
11/20/2013CN103402517A Method of treatment with BRAF inhibitor
11/20/2013CN103402515A Sgc stimulators
11/20/2013CN103396414A Imidazolyl-substituted thiazocyclohexane compounds and antitumor application thereof
11/20/2013CN103396412A Modifier of 5-HT2A serotonin receptor
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN103396398A Prokineticin 1 receptor antagonists
11/20/2013CN103396321A Alcohol-soluble conjugate organic micromolecular material for cathode interface of solar cell, and preparation method and purpose thereof
11/20/2013CN102167697B Novel structure, synthesis method and application of hypoxia injury resistant compounds
11/20/2013CN101896483B Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
11/20/2013CN101090900B Process for preparation of high-purity meloxicam and meloxicam potassium salt
11/19/2013US8586739 Heterocyclic compounds and their uses
11/19/2013US8586611 Fungicidal carboxamides
11/19/2013US8586609 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/19/2013US8586578 Deuterated 5,6-dihydro-1H-pyridin-2-one compounds
11/19/2013US8586571 Heterocyclic compound
11/19/2013US8586505 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
11/19/2013CA2707418C Inhibitors of human immunodeficiency virus replication
11/19/2013CA2618340C Piperidine and piperazine derivatives as p2x3 antagonists
11/19/2013CA2602750C Pharmaceutical preparation of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide
11/19/2013CA2558848C Isoxazoline-substituted benzamide compound and pesticide
11/14/2013WO2013170186A1 Carbazole-containing sulfonamides as cryptochrome modulators
11/14/2013WO2013170118A1 Thiazolecarboxamide derivatives for use as nampt inhibitors
11/14/2013WO2013170115A1 Pyridazine and pyridine derivatives as nampt inhibitors
11/14/2013WO2013170113A1 Nampt inhibitors
11/14/2013WO2013167495A1 Bicyclically substituted uracils and the use thereof
11/14/2013WO2013079586A4 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof
11/14/2013US20130303779 Process for the preparation of diol sulfones
11/14/2013US20130303572 Novel inhibitors of matrix metalloproteinases
11/14/2013US20130303544 Benzopyrone estrogen receptor regulator
11/14/2013US20130303542 Substituted pyrazinamide compounds for inflammation and immune-related uses
11/14/2013US20130303525 Kappa opioid receptor agonists
11/14/2013US20130303524 Carbazole-Containing Sulfonamides as Cryptochrome Modulators
11/14/2013US20130303517 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
11/14/2013US20130303516 Novel triazine compounds
11/14/2013US20130303515 Novel compounds useful for the treatment of metabolic and inflammatory diseases
11/14/2013US20130303509 Nampt inhibitors
11/14/2013US20130303491 Antiviral Drugs for Treatement or Prevention of Dengue Infection
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 628